Induction Immunotherapy in Elderly Kidney Transplant Recipients - Comparison between Alemtuzumab, Thymoglobulin and Basiliximab Induction Agents Long-Term Outcomes.

被引：0
|
作者：
Zachariah, M. [1 ]
Nader, N. [1 ]
Shah, S. [1 ]
Kandakurti, K. [1 ]
Venuto, R. [1 ]
Pankewycz, O. [1 ]
Laftavi, M. [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY 14260 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
985
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [41] Delayed Calcineurin Inhibitor Introduction and Long Term Renal Outcomes in Liver Transplant Recipients Receiving Basiliximab Induction
    Lange, N.
    Salerno, D.
    Sammons, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 777 - 778
  • [42] Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 955 - 956
  • [43] Long-Term Effect of Alemtuzumab Induction on T Cell Memory and T Regulatory Cell (Treg) Subsets in Kidney Transplant Recipients
    Macedo, Camila
    Orkis, Elizabeth
    Elinoff, Beth
    Fedorek, Sheila
    Bentlejewski, Carol
    Lunz, John
    Zeevi, Adriana
    Lakkis, Fadi
    Shapiro, Ron
    Metes, Diana
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 489 - 489
  • [44] Long-Term Outcomes after Alemtuzumab Induction in Lung Transplantation
    Shyu, S.
    Dew, M. A.
    Dabbs, A. De Vito
    Crespo, M.
    Zaldonts, D. B.
    Johnson, B. A.
    Studer, S. M.
    Toyoda, Y.
    Bermudez, C. A.
    Hattler, B. G.
    Pilewski, J. M.
    McCurry, K. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S68 - S68
  • [45] Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients
    Sifontis, N. M.
    Coleman, A.
    Tang, D.
    Lau, K.
    Karhadkar, S.
    DiCarlo, A.
    Diamond, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 688 - 689
  • [46] Post-Kidney Transplant Neutropenia After Alemtuzumab Induction: Risk Factors and Graft Outcomes.
    Zachariah, M.
    Fallahzadeh, M.
    Gumber, R.
    Kumar, A.
    Patel, S.
    Sharma, R.
    Singh, N.
    Gudleski, G.
    Venuto, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 582 - 582
  • [47] Choice of Induction in HIV-Infected Kidney Transplant Recipients and Its Impact On Transplant Outcomes.
    Manitpisitkul, W.
    Sparkes, T.
    Pickard, M.
    Masters, B.
    Bartlett, S.
    Davis, C.
    Amoroso, A.
    Weir, M.
    Haririan, A.
    TRANSPLANTATION, 2014, 98 : 584 - 585
  • [48] Long-Term Outcomes following Alemtuzumab Induction in Lung Transplantation
    Wehman, Brody
    Griffith, Bartley P.
    Balwan, Akshu
    Kon, Zachary N.
    Suffredini, Dante A.
    Evans, Charles
    Garcia, Jose P.
    Iacono, Aldo
    HEART SURGERY FORUM, 2013, 16 (05): : E252 - E256
  • [49] Post-Kidney Transplant Neutropenia After Alemtuzumab Induction: Risk Factors and Graft Outcomes.
    Zachariah, M.
    Fallahzadeh, M.
    Gumber, R.
    Kumar, A.
    Patel, S.
    Sharma, R.
    Singh, N.
    Gudleski, G.
    Venuto, R.
    TRANSPLANTATION, 2014, 98 : 582 - 582
  • [50] Long-term results of basiliximab induction immunosuppression in pediatric liver graft recipients
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 40 (05): : 670 - 670
12345